Treatment of patients with severe sepsis and septic shock: real-life lessons

Pharmaceutical companies have provided a great deal of education focused on products such as rhAPC. Unfortunately, educational funding to promote the use of equally efficacious but inexpensive therapies, such as steroids, fluids or pressure monitoring, is lacking. Early goal-directed therapy saves lives, and mortality increases for each hour that appropriate antibiotics and fluid resuscitation are delayed.2,3 With any time-dependant therapy, it is necessary to expedite a continuum of care.